BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33334704)

  • 1. Validation of fatty liver disease scoring systems for ultrasound diagnosed non-alcoholic fatty liver disease in adolescents.
    Wan F; Pan F; Ayonrinde OT; Adams LA; Mori TA; Beilin LJ; O'Sullivan TA; Olynyk JK; Oddy WH
    Dig Liver Dis; 2021 Jun; 53(6):746-752. PubMed ID: 33334704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of noninvasive indexes of adults in identification of nonalcoholic fatty liver disease in children.
    Shi M; Liu P; Li J; Su Y; Zhou X; Wu C; Chen X; Zheng C
    J Diabetes; 2021 Sep; 13(9):744-753. PubMed ID: 33576570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of fatty liver index and hepatic steatosis index for screening of non-alcoholic fatty liver disease in adults with obstructive sleep apnea hypopnea syndrome.
    Chen LD; Huang JF; Chen QS; Lin GF; Zeng HX; Lin XF; Lin XJ; Lin L; Lin QC
    Chin Med J (Engl); 2019 Nov; 132(22):2670-2676. PubMed ID: 31765354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fatty liver biomarkers and insulin resistance indices in the prediction of non-alcoholic fatty liver disease in Ghanaian patients.
    Bockarie AS; Nartey YA; Nsiah P; Edzie EKM; Tuoyire D; Acquah S; Eliason S; Nkum B
    Endocrinol Diabetes Metab; 2023 Nov; 6(6):e456. PubMed ID: 37814510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development, external validation, and comparative assessment of a new diagnostic score for hepatic steatosis.
    Meffert PJ; Baumeister SE; Lerch MM; Mayerle J; Kratzer W; Völzke H
    Am J Gastroenterol; 2014 Sep; 109(9):1404-14. PubMed ID: 24957156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External Validation of Surrogate Indices of Fatty Liver in the General Population: the Bagnacavallo Study.
    Foschi FG; Conti F; Domenicali M; Giacomoni P; Borghi A; Bevilacqua V; Napoli L; Berardinelli D; Altini M; Cucchetti A; Ercolani G; Casadei-Gardini A; Bellentani S; Gastaldelli A; Tiribelli C; Bedogni G; Group BS
    J Clin Med; 2021 Feb; 10(3):. PubMed ID: 33535679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of nonalcoholic fatty liver disease (NAFLD) related steatosis indices in metabolic associated fatty liver disease (MAFLD) and comparison of the diagnostic accuracy between NAFLD and MAFLD.
    Chen J; Mao X; Deng M; Luo G
    Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):394-401. PubMed ID: 36695773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ZJU index is a powerful index for identifying NAFLD in the general Chinese population.
    Li L; You W; Ren W
    Acta Diabetol; 2017 Oct; 54(10):905-911. PubMed ID: 28698957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of non-invasive indicators in the screening of metabolic dysfunction-associated fatty liver disease: a cross-sectional study among Uighurs in rural Xinjiang.
    Guo Y; Hu Y; Yang J; Ma R; Zhang X; Guo H; Wang X; Li Y; Peng X; Zhang S; He J; Guo S
    Eur J Med Res; 2023 Dec; 28(1):555. PubMed ID: 38042816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visceral adiposity index for the diagnosis of nonalcoholic fatty liver disease in premenopausal women with and without polycystic ovary syndrome.
    Vassilatou E; Lafoyianni S; Vassiliadi DA; Ioannidis D; Paschou SA; Mizamtsidi M; Panagou M; Vryonidou A
    Maturitas; 2018 Oct; 116():1-7. PubMed ID: 30244768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies].
    Nosov AE; Zenina MT; Gorbushina OY; Baidina AS; Vlasova EM; Alekseev VB
    Ter Arkh; 2021 Aug; 93(8):883-889. PubMed ID: 36286882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validation and comparison of simple tools to screen for nonalcoholic fatty liver disease in Chinese community population.
    Zhang L; Zhang M; Wang M; Wang M; Zhang R; Wang H; Zhang W; Ding Y; Wang J
    Eur J Gastroenterol Hepatol; 2022 Aug; 34(8):865-872. PubMed ID: 35802528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of Nonalcoholic Fatty Liver Disease Using Noninvasive and Non-Imaging Procedures in Japanese Health Checkup Examinees.
    Murayama K; Okada M; Tanaka K; Inadomi C; Yoshioka W; Kubotsu Y; Yada T; Isoda H; Kuwashiro T; Oeda S; Akiyama T; Oza N; Hyogo H; Ono M; Kawaguchi T; Torimura T; Anzai K; Eguchi Y; Takahashi H
    Diagnostics (Basel); 2021 Jan; 11(1):. PubMed ID: 33467114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.
    Cen C; Wang W; Yu S; Tang X; Liu J; Liu Y; Zhou L; Yu J; Zheng S
    Hepatol Int; 2020 Sep; 14(5):808-816. PubMed ID: 32572817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic accuracy of a noninvasive hepatic ultrasound score for non-alcoholic fatty liver disease (NAFLD) in the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil).
    Goulart AC; Oliveira IR; Alencar AP; Santos MS; Santos IS; Martines BM; Meireles DP; Martines JA; Misciagna G; Benseñor IM; Lotufo PA
    Sao Paulo Med J; 2015; 133(2):115-24. PubMed ID: 26018881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Hepatic Steatosis Index and Fatty Liver Index with Carotid Atherosclerosis in Type 2 Diabetes.
    Wang C; Cai Z; Deng X; Li H; Zhao Z; Guo C; Zhang P; Li L; Gu T; Yang L; Zhao L; Wang D; Yuan G
    Int J Med Sci; 2021; 18(14):3280-3289. PubMed ID: 34400897
    [No Abstract]   [Full Text] [Related]  

  • 18. The ZJU index is a powerful surrogate marker for NAFLD in severely obese North American women.
    Fu CP; Ali H; Rachakonda VP; Oczypok EA; DeLany JP; Kershaw EE
    PLoS One; 2019; 14(11):e0224942. PubMed ID: 31770380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the ZJU index and risk of new-onset non-alcoholic fatty liver disease in non-obese participants: a Chinese longitudinal prospective cohort study.
    Zheng K; Yin Y; Guo H; Ma L; Liu R; Zhao T; Wei Y; Zhao Z; Cheng W
    Front Endocrinol (Lausanne); 2024; 15():1340644. PubMed ID: 38405152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver index (FLI) and prediction of new cases of non-alcoholic fatty liver disease: A population-based study of northern Iran.
    Motamed N; Faraji AH; Khonsari MR; Maadi M; Tameshkel FS; Keyvani H; Ajdarkosh H; Karbalaie Niya MH; Rezaie N; Zamani F
    Clin Nutr; 2020 Feb; 39(2):468-474. PubMed ID: 30922791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.